Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (600329) under the Base Case is 26.27 CNY per share.
Compared with the current market price of 40.05 CNY, the stock appears
Overvalued by 34% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Tianjin Pharmaceutical Da Ren Tang Group Does
Tianjin Pharmaceutical Da Ren Tang Group makes and sells traditional Chinese medicines, prescription drugs, over-the-counter remedies, and related health products. Its core business is turning classic Da Ren Tang formulas into branded medicines that are sold through pharmacies, hospitals, distributors, and direct retail channels. The company earns money by manufacturing these products and selling them under its own brand.
- Headquarters
- China CN
- Employees
- 3 890
- IPO date
- Jun 6, 2001
Revenue & Expenses Breakdown
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
What is the Intrinsic Value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock?
The intrinsic value for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (600329) under the Base Case is 26.27 CNY.
Is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock undervalued or overvalued?
Compared with the current market price of 40.05 CNY, the stock appears Overvalued by 34% .
